Xi'an Faithful BioTech Co., Ltd. is selling RU58841 Raw Powder. Please feel free to contact us if you have any purchase needs.
Send your Inquiry for more details, Click email：sales4@faithfulbio.com
I. Basic Chemical Characteristics of RU58841
RU58841 is a structurally well-defined nonsteroidal compound, chemically an aryl hydantoin derivative. It possesses specific molecular structure and physicochemical properties, which form the basis for its biological activity.
1.1 Core Chemical Information
According to publicly available research data, the chemical parameters of RU58841 are clearly marked: CAS number 154992-24-2, PubChem compound identification number (CID) 132981. Molecularly, it has the formula C₁₇H₁₈F₃N₃O₃ and a molecular weight of 369.344 g·mol⁻¹. Its molecular structure contains key functional groups such as an imidazolidinedione (hydantoin) ring, trifluoromethyl, cyano, and hydroxybutyl groups. The presence of these functional groups determines its chemical activity and biological targeting.
The core feature of its molecular structure is the hydantoin ring (a five-membered nitrogen-containing heterocycle), which connects the hydroxybutyl side chain and the aromatic ring structure via a nitrogen atom. The aromatic ring is simultaneously substituted with a trifluoromethyl group (-CF₃) and a cyano group (-C≡N). This structural design allows it to retain the lipophilic characteristics of nonsteroidal compounds while enhancing its affinity for local tissues through the hydrophilic group of the hydroxybutyl group, laying the structural foundation for its subsequent local application research. Furthermore, the chemical structure of RU58841 is similar to that of another nonsteroidal anti-androgen, RU-58642, with the main difference being the different side chain structures. This structural difference also leads to subtle differences in their biological activities and metabolic pathways.
1.2 Physical and Chemical Properties
Physically, RU58841 usually exists as a white or off-white powder with high purity standards. The purity of industrially synthesized and research products generally reaches over 98% (HPLC detection). Its solubility exhibits a clear polarity dependence, readily soluble in organic solvents such as ethanol and dimethyl sulfoxide (DMSO), and slightly soluble in water. This solubility characteristic makes it suitable for preparation into topical formulations, such as alcohol solutions and gels. Regarding storage conditions, this compound is sensitive to temperature and humidity; it is recommended to store it under sealed refrigeration at -20°C. The powder form is stable for 3 years, while the stock solution dissolved in a solvent can be stored for 1 year at -80°C. Repeated freeze-thaw cycles will affect its stability.
Chemically, RU58841 possesses a certain degree of stability and is not easily decomposed under neutral and weakly acidic conditions. However, it may undergo ring cleavage and side-chain hydrolysis reactions in strongly acidic or alkaline environments. The cyano and trifluoromethyl groups in its molecule have strong electron-withdrawing effects, reducing the electron cloud density on the aromatic ring and enhancing its binding ability with biomolecules (such as receptors). The hydroxyl group on the hydroxybutyl side chain can undergo esterification, a property that also provides possibilities for its precursor development. For example, the RU58841-myristate precursor can be prepared via esterification to improve its local penetration and metabolic stability.
II. Mechanism of Action of RU58841
The core biological activity of RU58841 is as a non-steroidal anti-androgen. Its mechanism of action mainly revolves around the targeted binding of the androgen receptor (AR), regulating androgen-dependent physiological processes by blocking the biological effects of androgens. This mechanism is also the core basis for its role in hair follicle health and skin problem intervention.
2.1 Targeted Binding of Androgen Receptors
The biological effects of androgens in vivo are mainly achieved through binding to intracellular androgen receptors (AR). Androgen receptors (ARs) belong to the nuclear receptor superfamily. When unbound, they are in an inactive state. Upon binding to androgens, they undergo a conformational change, forming an active complex that enters the cell nucleus. There, they bind to specific DNA sequences (androgen response elements), regulating the transcription and expression of downstream genes, thereby influencing cell proliferation, differentiation, and apoptosis.
RU58841, as an androgen receptor antagonist, firstly achieves its action by specifically binding to ARs. Research data shows that RU58841 has a high affinity for ARs, with a relative binding affinity (RBA) of 150%, higher than other non-steroidal anti-androgens. Its binding site is the same as that of androgens, competitively binding to ARs and preventing the binding of endogenous androgens to ARs, thus inhibiting AR activation. Notably, RU58841 exhibits extremely low affinity (<0.1%) for other steroid hormone receptors such as estrogen receptors (ER), progesterone receptors (PR), and glucocorticoid receptors (GR). This high receptor selectivity gives its biological action strong targeting, reducing interference with other physiological systems.
2.2 Mechanism of Biological Effect Blocking
When RU58841 binds to AR, although it causes a conformational change in the receptor, this conformational change fails to form a transcriptionally active complex, or the resulting complex is extremely unstable and cannot effectively bind to DNA and initiate downstream gene expression. Specifically, its blocking effect is mainly manifested in two aspects: first, it directly occupies the ligand-binding domain of AR, preventing the binding of potent androgens and interrupting the initiation of androgen signaling; second, the RU58841-AR complex formed after binding is unlikely to interact with co-activators, and may instead recruit co-repressors, further inhibiting the transcription of downstream genes, thereby weakening the regulatory effect of androgens on target cells.
Send your Inquiry for more details, Click email：sales4@faithfulbio.com
III. Potential Application Scenarios of RU58841
Based on its anti-androgen mechanism of action and existing experimental research results, the potential applications of RU58841 mainly focus on the local intervention of androgen-dependent physiological problems, primarily including hair health maintenance and skin problem intervention. There is also room for exploration in other potential application directions.
3.1 Local Intervention for Androgenetic Alopecia
Androgenetic alopecia (also known as seborrheic alopecia, male pattern baldness/female pattern thinning) is the most common type of hair loss, and its pathogenesis is closely related to genetic factors and androgen levels. Currently, local intervention methods for this problem are relatively limited. RU58841, with its mechanism of action of targeting androgen signaling and protecting hair follicles, has become one of the most promising research directions in this field.
Based on animal experiments and limited human exploratory studies, RU58841's advantages are mainly reflected in three aspects: First, it has strong targeting, acting directly on the AR within hair follicle cells to fundamentally slow down the miniaturization process of hair follicles; second, it primarily acts locally, with extremely low systemic absorption; and third, it can promote the hair follicle cycle, increasing hair growth rate, not only preventing hair loss but also potentially promoting the recovery of resting hair follicles, thus increasing hair density.
It is important to note that RU58841 is primarily suitable for patients with androgen-dependent alopecia. Its effectiveness may be limited for non-androgen-dependent alopecia such as those caused by blood deficiency, postpartum hair loss, or malnutrition. Furthermore, its effectiveness varies from person to person and is closely related to factors such as the degree of hair loss, hair follicle survival status, concentration, and frequency of use.
3.2 Intervention for Acne and Oily Skin Problems
One of the pathogenesis mechanisms of acne is that excessively high androgen levels lead to excessive sebum secretion, which clogs the hair follicle opening, subsequently triggering bacterial infection and inflammatory responses. Because RU58841 can block androgen signaling and inhibit sebaceous gland cell proliferation and sebum secretion, it has potential application value in the intervention of acne and oily skin problems.
In vitro and animal experiments have confirmed that RU58841 can significantly reduce sebum secretion, lower the sebum content on the skin surface, and inhibit the growth of Propionibacterium acnes (indirect effect), thereby reducing the release of inflammatory factors and alleviating acne symptoms. Compared with traditional topical intervention ingredients, the advantage of RU58841 lies in its more fundamental mechanism of action (starting from regulating sebaceous gland function), rather than simply antibacterial or anti-inflammatory. It may be more targeted at stubborn acne caused by high androgen levels (such as late-onset acne in adult women and chest and back acne in men).
Furthermore, topical application of RU58841 may also improve problems such as oily skin and enlarged pores by reducing sebum secretion, lowering the risk of clogged hair follicles, and reducing the impact of oil on the balance of skin surface flora, resulting in more stable skin condition. However, current research on its application in acne intervention is still in the in vitro and animal testing stage, lacking human clinical trial data. Its efficacy and safety require further verification.
3.3 Other Potential Applications
Besides hair and skin, the anti-androgen effect of RU58841 provides insights for research on other androgen-dependent problems. For example, in the intervention of hirsutism (localized excessive hair growth, such as on the lips and jawline in women), RU58841 can inhibit excessive hair follicle proliferation and reduce hair growth rate and density by blocking local androgen signaling, showing potential value for local intervention. However, research in this direction has not yet conducted systematic experimental exploration and remains at the theoretical speculation stage.
In the field of basic medical research, RU58841 is often used as a tool compound for androgen receptor research, used to construct androgen signaling pathway blocking models and explore the physiological functions of androgens in the reproductive system, endocrine system, skin, and hair follicles. Its high AR selectivity makes it an ideal tool for research in this field, providing important support for related basic research.
IV. Limitations and Future Prospects of RU58841 Research
Although RU58841 has significant advantages in terms of its mechanism of action and potential applications, current research still faces several limitations, which determine its future research direction and application prospects.
4.1 Core Limitations of Existing Research
The limitations of RU58841 research are mainly reflected in three aspects: First, human studies are severely insufficient. Currently, there is a lack of large-sample, long-term follow-up, randomized controlled clinical trials, making it impossible to fully confirm its efficacy and long-term safety in humans. Second, the details of its mechanism of action are not yet fully clear. Although it is known to exert its effect by blocking AR, research on its downstream gene regulatory networks, interactions with other signaling pathways, and the molecular mechanisms of individual differences is still insufficient. Third, dosage form development is still imperfect. Existing dosage forms still have room for improvement in terms of stability, targeting, and comfort, and the lack of standardized formulations and manufacturing processes leads to inconsistent product quality from different sources.
Furthermore, the synthesis cost of RU58841 is relatively high, and large-scale industrial production processes still need optimization, which also limits the large-scale development of its research. Meanwhile, its applicability to different populations (such as those of different ages, genders, and degrees of hair loss) remains unclear, making it impossible to develop targeted usage plans.
4.2 Future Research and Application Prospects
To address the limitations of existing research, future research on RU58841 will focus on the following directions: First, conducting high-quality human clinical trials, including a sufficient sample size of subjects, setting up a strict control group, and conducting long-term follow-up to evaluate its efficacy and safety, clarifying its applicable population and usage plan; Second, exploring its mechanism of action in depth, using genomics, transcriptomics, and other technologies to analyze its downstream gene regulatory network, elucidating the molecular basis of individual differences, and providing theoretical support for precision application; Third, optimizing the synthesis process and dosage form development, reducing synthesis costs, improving the stability, targeting, and comfort of the dosage form, and developing standardized formulation products; Fourth, expanding its application areas, conducting experimental explorations in areas such as hirsutism and other androgen-dependent skin problems, and exploring its potential application value.
From an application perspective, if the efficacy and safety of RU58841 can be demonstrated through high-quality clinical trials and approved by relevant regulatory agencies, it is expected to become a novel topical intervention ingredient for androgenetic alopecia, acne, and other related issues, providing more intervention options for affected populations. Especially in the field of androgenetic alopecia intervention, its mechanism of targeting androgen signaling may compensate for the shortcomings of existing topical interventions, and can be used in combination with existing ingredients to form more efficient intervention programs.
It is important to emphasize that the research and application of RU58841 is still in the exploratory stage, and many uncertainties remain. Its potential value should be viewed rationally, and overstatement or indiscriminate use should be avoided. In the future, as research continues, its mechanism of action will become clearer, and its safety and efficacy will be more fully verified, potentially allowing it to play an important role in related fields.
Conclusion
RU58841, a nonsteroidal anti-androgen compound, possesses a well-defined chemical structure and mechanism of action. Experimental studies on its effects on hair follicle protection, hair growth promotion, and sebaceous gland function regulation demonstrate significant potential application value. Chemically, its specific molecular structure endows it with high androgen receptor targeting. In terms of synthesis, the optimized three-step process significantly improves its yield and safety. Research progress shows that animal experiments and a small number of exploratory human studies have confirmed its biological activity, but high-quality clinical data are still lacking. Regarding safety, topical application carries certain risks of irritation and potential endocrine effects, requiring strict adherence to regulations.
Overall, RU58841 is a compound of significant research value. Its future development depends on high-quality clinical trials, in-depth analysis of its mechanism of action, and continuous optimization of dosage forms and processes. For the general public, its potential applications should be viewed rationally, and the use of unapproved products should be avoided. For researchers, it provides important tools and insights for the study of androgen-dependent diseases, warranting further in-depth exploration. It is believed that as research continues to advance, RU58841 will play an increasingly important role in areas such as hair health and skin care, providing new solutions for the intervention of related diseases.
As a provider of premium RU58841 CAS 154992-24-2, Xi'an Faithful BioTech Co., Ltd. leverages state-of-the-art production technology and rigorous quality assurance to meet international pharmaceutical requirements. Our dedication to superior quality, cost-effective pricing, and tailored technical support has made us the preferred collaborator for healthcare professionals and researchers worldwide. To obtain detailed specifications and application guidance for our RU58841 Powder, contact our technical team at sales4@faithfulbio.com and explore how our offerings can enhance your product formulations.